[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Testosterone Replacement Injectables Market Growth 2024-2030

June 2024 | 141 pages | ID: GE3D5B446334EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Testosterone replacement therapy (TRT) is a medical intervention designed to address low testosterone levels in individuals, particularly men. Testosterone, a key male sex hormone, plays a crucial role in various bodily functions, including the development of secondary sexual characteristics, maintaining bone density, muscle mass, and energy levels. When testosterone levels decline due to aging, medical conditions, or other factors, individuals experience symptoms such as fatigue, reduced libido, mood swings, and diminished cognitive function. Testosterone replacement therapy aims to restore testosterone levels to normal ranges, alleviating these symptoms and potentially improving overall well-being. Injection is the common methods of administering testosterone replacement therapy.

The global Testosterone Replacement Injectables market size is projected to grow from US$ 1344 million in 2024 to US$ 1729 million in 2030; it is expected to grow at a CAGR of 4.3% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Testosterone Replacement Injectables Industry Forecast” looks at past sales and reviews total world Testosterone Replacement Injectables sales in 2023, providing a comprehensive analysis by region and market sector of projected Testosterone Replacement Injectables sales for 2024 through 2030. With Testosterone Replacement Injectables sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Testosterone Replacement Injectables industry.

This Insight Report provides a comprehensive analysis of the global Testosterone Replacement Injectables landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Testosterone Replacement Injectables portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Testosterone Replacement Injectables market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Testosterone Replacement Injectables and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Testosterone Replacement Injectables.

According to 2023 report by National Library of Medicine it was reported that hypogonadism occurs in 19% of men in their 60s, 28% of men in their 70s, and 49% of men in their 80s. In addition, according to the World Health Organization, it was reported that by 2030, 1 in 6 people in the world are expected to be aged 60 years or over. Furthermore, according to a 2023 report by the National Library of Medicine, it was reported that hypogonadism is common in geriatric patients.

This report presents a comprehensive overview, market shares, and growth opportunities of Testosterone Replacement Injectables market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Testosterone Undecanoate
  • Testosterone Cypionate
  • Testosterone Enanthate
  • Others
Segmentation by Application:
  • Hospital
  • Clinics
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Marius Pharmaceuticals
  • Insud Pharma S.L
  • AbbVie Inc
  • Acrux Ltd
  • Besins Healthcare SA
  • Pfizer Inc
  • Acerus Pharmaceuticals Corporation
  • Amneal Pharmaceuticals Inc
  • Biote Medical LLC
  • Endo International Plc
  • Eli lilly
  • Actavis (Allergan)
  • Bayer
  • Novartis
  • Teva
  • Mylan
  • Upsher-Smith
  • Ferring Pharmaceuticals
  • Kyowa Kirin
Key Questions Addressed in this Report

What is the 10-year outlook for the global Testosterone Replacement Injectables market?

What factors are driving Testosterone Replacement Injectables market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Testosterone Replacement Injectables market opportunities vary by end market size?

How does Testosterone Replacement Injectables break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Testosterone Replacement Injectables Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Testosterone Replacement Injectables by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Testosterone Replacement Injectables by Country/Region, 2019, 2023 & 2030
2.2 Testosterone Replacement Injectables Segment by Type
  2.2.1 Testosterone Undecanoate
  2.2.2 Testosterone Cypionate
  2.2.3 Testosterone Enanthate
  2.2.4 Others
2.3 Testosterone Replacement Injectables Sales by Type
  2.3.1 Global Testosterone Replacement Injectables Sales Market Share by Type (2019-2024)
  2.3.2 Global Testosterone Replacement Injectables Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Testosterone Replacement Injectables Sale Price by Type (2019-2024)
2.4 Testosterone Replacement Injectables Segment by Application
  2.4.1 Hospital
  2.4.2 Clinics
  2.4.3 Others
2.5 Testosterone Replacement Injectables Sales by Application
  2.5.1 Global Testosterone Replacement Injectables Sale Market Share by Application (2019-2024)
  2.5.2 Global Testosterone Replacement Injectables Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Testosterone Replacement Injectables Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Testosterone Replacement Injectables Breakdown Data by Company
  3.1.1 Global Testosterone Replacement Injectables Annual Sales by Company (2019-2024)
  3.1.2 Global Testosterone Replacement Injectables Sales Market Share by Company (2019-2024)
3.2 Global Testosterone Replacement Injectables Annual Revenue by Company (2019-2024)
  3.2.1 Global Testosterone Replacement Injectables Revenue by Company (2019-2024)
  3.2.2 Global Testosterone Replacement Injectables Revenue Market Share by Company (2019-2024)
3.3 Global Testosterone Replacement Injectables Sale Price by Company
3.4 Key Manufacturers Testosterone Replacement Injectables Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Testosterone Replacement Injectables Product Location Distribution
  3.4.2 Players Testosterone Replacement Injectables Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TESTOSTERONE REPLACEMENT INJECTABLES BY GEOGRAPHIC REGION

4.1 World Historic Testosterone Replacement Injectables Market Size by Geographic Region (2019-2024)
  4.1.1 Global Testosterone Replacement Injectables Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Testosterone Replacement Injectables Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Testosterone Replacement Injectables Market Size by Country/Region (2019-2024)
  4.2.1 Global Testosterone Replacement Injectables Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Testosterone Replacement Injectables Annual Revenue by Country/Region (2019-2024)
4.3 Americas Testosterone Replacement Injectables Sales Growth
4.4 APAC Testosterone Replacement Injectables Sales Growth
4.5 Europe Testosterone Replacement Injectables Sales Growth
4.6 Middle East & Africa Testosterone Replacement Injectables Sales Growth

5 AMERICAS

5.1 Americas Testosterone Replacement Injectables Sales by Country
  5.1.1 Americas Testosterone Replacement Injectables Sales by Country (2019-2024)
  5.1.2 Americas Testosterone Replacement Injectables Revenue by Country (2019-2024)
5.2 Americas Testosterone Replacement Injectables Sales by Type (2019-2024)
5.3 Americas Testosterone Replacement Injectables Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Testosterone Replacement Injectables Sales by Region
  6.1.1 APAC Testosterone Replacement Injectables Sales by Region (2019-2024)
  6.1.2 APAC Testosterone Replacement Injectables Revenue by Region (2019-2024)
6.2 APAC Testosterone Replacement Injectables Sales by Type (2019-2024)
6.3 APAC Testosterone Replacement Injectables Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Testosterone Replacement Injectables by Country
  7.1.1 Europe Testosterone Replacement Injectables Sales by Country (2019-2024)
  7.1.2 Europe Testosterone Replacement Injectables Revenue by Country (2019-2024)
7.2 Europe Testosterone Replacement Injectables Sales by Type (2019-2024)
7.3 Europe Testosterone Replacement Injectables Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Testosterone Replacement Injectables by Country
  8.1.1 Middle East & Africa Testosterone Replacement Injectables Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Testosterone Replacement Injectables Revenue by Country (2019-2024)
8.2 Middle East & Africa Testosterone Replacement Injectables Sales by Type (2019-2024)
8.3 Middle East & Africa Testosterone Replacement Injectables Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Testosterone Replacement Injectables
10.3 Manufacturing Process Analysis of Testosterone Replacement Injectables
10.4 Industry Chain Structure of Testosterone Replacement Injectables

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Testosterone Replacement Injectables Distributors
11.3 Testosterone Replacement Injectables Customer

12 WORLD FORECAST REVIEW FOR TESTOSTERONE REPLACEMENT INJECTABLES BY GEOGRAPHIC REGION

12.1 Global Testosterone Replacement Injectables Market Size Forecast by Region
  12.1.1 Global Testosterone Replacement Injectables Forecast by Region (2025-2030)
  12.1.2 Global Testosterone Replacement Injectables Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Testosterone Replacement Injectables Forecast by Type (2025-2030)
12.7 Global Testosterone Replacement Injectables Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Marius Pharmaceuticals
  13.1.1 Marius Pharmaceuticals Company Information
  13.1.2 Marius Pharmaceuticals Testosterone Replacement Injectables Product Portfolios and Specifications
  13.1.3 Marius Pharmaceuticals Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Marius Pharmaceuticals Main Business Overview
  13.1.5 Marius Pharmaceuticals Latest Developments
13.2 Insud Pharma S.L
  13.2.1 Insud Pharma S.L Company Information
  13.2.2 Insud Pharma S.L Testosterone Replacement Injectables Product Portfolios and Specifications
  13.2.3 Insud Pharma S.L Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Insud Pharma S.L Main Business Overview
  13.2.5 Insud Pharma S.L Latest Developments
13.3 AbbVie Inc
  13.3.1 AbbVie Inc Company Information
  13.3.2 AbbVie Inc Testosterone Replacement Injectables Product Portfolios and Specifications
  13.3.3 AbbVie Inc Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 AbbVie Inc Main Business Overview
  13.3.5 AbbVie Inc Latest Developments
13.4 Acrux Ltd
  13.4.1 Acrux Ltd Company Information
  13.4.2 Acrux Ltd Testosterone Replacement Injectables Product Portfolios and Specifications
  13.4.3 Acrux Ltd Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Acrux Ltd Main Business Overview
  13.4.5 Acrux Ltd Latest Developments
13.5 Besins Healthcare SA
  13.5.1 Besins Healthcare SA Company Information
  13.5.2 Besins Healthcare SA Testosterone Replacement Injectables Product Portfolios and Specifications
  13.5.3 Besins Healthcare SA Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Besins Healthcare SA Main Business Overview
  13.5.5 Besins Healthcare SA Latest Developments
13.6 Pfizer Inc
  13.6.1 Pfizer Inc Company Information
  13.6.2 Pfizer Inc Testosterone Replacement Injectables Product Portfolios and Specifications
  13.6.3 Pfizer Inc Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Pfizer Inc Main Business Overview
  13.6.5 Pfizer Inc Latest Developments
13.7 Acerus Pharmaceuticals Corporation
  13.7.1 Acerus Pharmaceuticals Corporation Company Information
  13.7.2 Acerus Pharmaceuticals Corporation Testosterone Replacement Injectables Product Portfolios and Specifications
  13.7.3 Acerus Pharmaceuticals Corporation Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Acerus Pharmaceuticals Corporation Main Business Overview
  13.7.5 Acerus Pharmaceuticals Corporation Latest Developments
13.8 Amneal Pharmaceuticals Inc
  13.8.1 Amneal Pharmaceuticals Inc Company Information
  13.8.2 Amneal Pharmaceuticals Inc Testosterone Replacement Injectables Product Portfolios and Specifications
  13.8.3 Amneal Pharmaceuticals Inc Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Amneal Pharmaceuticals Inc Main Business Overview
  13.8.5 Amneal Pharmaceuticals Inc Latest Developments
13.9 Biote Medical LLC
  13.9.1 Biote Medical LLC Company Information
  13.9.2 Biote Medical LLC Testosterone Replacement Injectables Product Portfolios and Specifications
  13.9.3 Biote Medical LLC Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Biote Medical LLC Main Business Overview
  13.9.5 Biote Medical LLC Latest Developments
13.10 Endo International Plc
  13.10.1 Endo International Plc Company Information
  13.10.2 Endo International Plc Testosterone Replacement Injectables Product Portfolios and Specifications
  13.10.3 Endo International Plc Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Endo International Plc Main Business Overview
  13.10.5 Endo International Plc Latest Developments
13.11 Eli lilly
  13.11.1 Eli lilly Company Information
  13.11.2 Eli lilly Testosterone Replacement Injectables Product Portfolios and Specifications
  13.11.3 Eli lilly Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Eli lilly Main Business Overview
  13.11.5 Eli lilly Latest Developments
13.12 Actavis (Allergan)
  13.12.1 Actavis (Allergan) Company Information
  13.12.2 Actavis (Allergan) Testosterone Replacement Injectables Product Portfolios and Specifications
  13.12.3 Actavis (Allergan) Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.12.4 Actavis (Allergan) Main Business Overview
  13.12.5 Actavis (Allergan) Latest Developments
13.13 Bayer
  13.13.1 Bayer Company Information
  13.13.2 Bayer Testosterone Replacement Injectables Product Portfolios and Specifications
  13.13.3 Bayer Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.13.4 Bayer Main Business Overview
  13.13.5 Bayer Latest Developments
13.14 Novartis
  13.14.1 Novartis Company Information
  13.14.2 Novartis Testosterone Replacement Injectables Product Portfolios and Specifications
  13.14.3 Novartis Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.14.4 Novartis Main Business Overview
  13.14.5 Novartis Latest Developments
13.15 Teva
  13.15.1 Teva Company Information
  13.15.2 Teva Testosterone Replacement Injectables Product Portfolios and Specifications
  13.15.3 Teva Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.15.4 Teva Main Business Overview
  13.15.5 Teva Latest Developments
13.16 Mylan
  13.16.1 Mylan Company Information
  13.16.2 Mylan Testosterone Replacement Injectables Product Portfolios and Specifications
  13.16.3 Mylan Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.16.4 Mylan Main Business Overview
  13.16.5 Mylan Latest Developments
13.17 Upsher-Smith
  13.17.1 Upsher-Smith Company Information
  13.17.2 Upsher-Smith Testosterone Replacement Injectables Product Portfolios and Specifications
  13.17.3 Upsher-Smith Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.17.4 Upsher-Smith Main Business Overview
  13.17.5 Upsher-Smith Latest Developments
13.18 Ferring Pharmaceuticals
  13.18.1 Ferring Pharmaceuticals Company Information
  13.18.2 Ferring Pharmaceuticals Testosterone Replacement Injectables Product Portfolios and Specifications
  13.18.3 Ferring Pharmaceuticals Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.18.4 Ferring Pharmaceuticals Main Business Overview
  13.18.5 Ferring Pharmaceuticals Latest Developments
13.19 Kyowa Kirin
  13.19.1 Kyowa Kirin Company Information
  13.19.2 Kyowa Kirin Testosterone Replacement Injectables Product Portfolios and Specifications
  13.19.3 Kyowa Kirin Testosterone Replacement Injectables Sales, Revenue, Price and Gross Margin (2019-2024)
  13.19.4 Kyowa Kirin Main Business Overview
  13.19.5 Kyowa Kirin Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Testosterone Replacement Injectables Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Testosterone Replacement Injectables Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Testosterone Undecanoate
Table 4. Major Players of Testosterone Cypionate
Table 5. Major Players of Testosterone Enanthate
Table 6. Major Players of Others
Table 7. Global Testosterone Replacement Injectables Sales by Type (2019-2024) & (K Units)
Table 8. Global Testosterone Replacement Injectables Sales Market Share by Type (2019-2024)
Table 9. Global Testosterone Replacement Injectables Revenue by Type (2019-2024) & ($ million)
Table 10. Global Testosterone Replacement Injectables Revenue Market Share by Type (2019-2024)
Table 11. Global Testosterone Replacement Injectables Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Testosterone Replacement Injectables Sale by Application (2019-2024) & (K Units)
Table 13. Global Testosterone Replacement Injectables Sale Market Share by Application (2019-2024)
Table 14. Global Testosterone Replacement Injectables Revenue by Application (2019-2024) & ($ million)
Table 15. Global Testosterone Replacement Injectables Revenue Market Share by Application (2019-2024)
Table 16. Global Testosterone Replacement Injectables Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Testosterone Replacement Injectables Sales by Company (2019-2024) & (K Units)
Table 18. Global Testosterone Replacement Injectables Sales Market Share by Company (2019-2024)
Table 19. Global Testosterone Replacement Injectables Revenue by Company (2019-2024) & ($ millions)
Table 20. Global Testosterone Replacement Injectables Revenue Market Share by Company (2019-2024)
Table 21. Global Testosterone Replacement Injectables Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Testosterone Replacement Injectables Producing Area Distribution and Sales Area
Table 23. Players Testosterone Replacement Injectables Products Offered
Table 24. Testosterone Replacement Injectables Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Testosterone Replacement Injectables Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Testosterone Replacement Injectables Sales Market Share Geographic Region (2019-2024)
Table 29. Global Testosterone Replacement Injectables Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Testosterone Replacement Injectables Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Testosterone Replacement Injectables Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Testosterone Replacement Injectables Sales Market Share by Country/Region (2019-2024)
Table 33. Global Testosterone Replacement Injectables Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Testosterone Replacement Injectables Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Testosterone Replacement Injectables Sales by Country (2019-2024) & (K Units)
Table 36. Americas Testosterone Replacement Injectables Sales Market Share by Country (2019-2024)
Table 37. Americas Testosterone Replacement Injectables Revenue by Country (2019-2024) & ($ millions)
Table 38. Americas Testosterone Replacement Injectables Sales by Type (2019-2024) & (K Units)
Table 39. Americas Testosterone Replacement Injectables Sales by Application (2019-2024) & (K Units)
Table 40. APAC Testosterone Replacement Injectables Sales by Region (2019-2024) & (K Units)
Table 41. APAC Testosterone Replacement Injectables Sales Market Share by Region (2019-2024)
Table 42. APAC Testosterone Replacement Injectables Revenue by Region (2019-2024) & ($ millions)
Table 43. APAC Testosterone Replacement Injectables Sales by Type (2019-2024) & (K Units)
Table 44. APAC Testosterone Replacement Injectables Sales by Application (2019-2024) & (K Units)
Table 45. Europe Testosterone Replacement Injectables Sales by Country (2019-2024) & (K Units)
Table 46. Europe Testosterone Replacement Injectables Revenue by Country (2019-2024) & ($ millions)
Table 47. Europe Testosterone Replacement Injectables Sales by Type (2019-2024) & (K Units)
Table 48. Europe Testosterone Replacement Injectables Sales by Application (2019-2024) & (K Units)
Table 49. Middle East & Africa Testosterone Replacement Injectables Sales by Country (2019-2024) & (K Units)
Table 50. Middle East & Africa Testosterone Replacement Injectables Revenue Market Share by Country (2019-2024)
Table 51. Middle East & Africa Testosterone Replacement Injectables Sales by Type (2019-2024) & (K Units)
Table 52. Middle East & Africa Testosterone Replacement Injectables Sales by Application (2019-2024) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Testosterone Replacement Injectables
Table 54. Key Market Challenges & Risks of Testosterone Replacement Injectables
Table 55. Key Industry Trends of Testosterone Replacement Injectables
Table 56. Testosterone Replacement Injectables Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Testosterone Replacement Injectables Distributors List
Table 59. Testosterone Replacement Injectables Customer List
Table 60. Global Testosterone Replacement Injectables Sales Forecast by Region (2025-2030) & (K Units)
Table 61. Global Testosterone Replacement Injectables Revenue Forecast by Region (2025-2030) & ($ millions)
Table 62. Americas Testosterone Replacement Injectables Sales Forecast by Country (2025-2030) & (K Units)
Table 63. Americas Testosterone Replacement Injectables Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 64. APAC Testosterone Replacement Injectables Sales Forecast by Region (2025-2030) & (K Units)
Table 65. APAC Testosterone Replacement Injectables Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Europe Testosterone Replacement Injectables Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Europe Testosterone Replacement Injectables Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Middle East & Africa Testosterone Replacement Injectables Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Middle East & Africa Testosterone Replacement Injectables Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Global Testosterone Replacement Injectables Sales Forecast by Type (2025-2030) & (K Units)
Table 71. Global Testosterone Replacement Injectables Revenue Forecast by Type (2025-2030) & ($ millions)
Table 72. Global Testosterone Replacement Injectables Sales Forecast by Application (2025-2030) & (K Units)
Table 73. Global Testosterone Replacement Injectables Revenue Forecast by Application (2025-2030) & ($ millions)
Table 74. Marius Pharmaceuticals Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 75. Marius Pharmaceuticals Testosterone Replacement Injectables Product Portfolios and Specifications
Table 76. Marius Pharmaceuticals Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 77. Marius Pharmaceuticals Main Business
Table 78. Marius Pharmaceuticals Latest Developments
Table 79. Insud Pharma S.L Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 80. Insud Pharma S.L Testosterone Replacement Injectables Product Portfolios and Specifications
Table 81. Insud Pharma S.L Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Insud Pharma S.L Main Business
Table 83. Insud Pharma S.L Latest Developments
Table 84. AbbVie Inc Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 85. AbbVie Inc Testosterone Replacement Injectables Product Portfolios and Specifications
Table 86. AbbVie Inc Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. AbbVie Inc Main Business
Table 88. AbbVie Inc Latest Developments
Table 89. Acrux Ltd Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 90. Acrux Ltd Testosterone Replacement Injectables Product Portfolios and Specifications
Table 91. Acrux Ltd Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Acrux Ltd Main Business
Table 93. Acrux Ltd Latest Developments
Table 94. Besins Healthcare SA Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 95. Besins Healthcare SA Testosterone Replacement Injectables Product Portfolios and Specifications
Table 96. Besins Healthcare SA Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Besins Healthcare SA Main Business
Table 98. Besins Healthcare SA Latest Developments
Table 99. Pfizer Inc Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 100. Pfizer Inc Testosterone Replacement Injectables Product Portfolios and Specifications
Table 101. Pfizer Inc Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Pfizer Inc Main Business
Table 103. Pfizer Inc Latest Developments
Table 104. Acerus Pharmaceuticals Corporation Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 105. Acerus Pharmaceuticals Corporation Testosterone Replacement Injectables Product Portfolios and Specifications
Table 106. Acerus Pharmaceuticals Corporation Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Acerus Pharmaceuticals Corporation Main Business
Table 108. Acerus Pharmaceuticals Corporation Latest Developments
Table 109. Amneal Pharmaceuticals Inc Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 110. Amneal Pharmaceuticals Inc Testosterone Replacement Injectables Product Portfolios and Specifications
Table 111. Amneal Pharmaceuticals Inc Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Amneal Pharmaceuticals Inc Main Business
Table 113. Amneal Pharmaceuticals Inc Latest Developments
Table 114. Biote Medical LLC Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 115. Biote Medical LLC Testosterone Replacement Injectables Product Portfolios and Specifications
Table 116. Biote Medical LLC Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Biote Medical LLC Main Business
Table 118. Biote Medical LLC Latest Developments
Table 119. Endo International Plc Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 120. Endo International Plc Testosterone Replacement Injectables Product Portfolios and Specifications
Table 121. Endo International Plc Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Endo International Plc Main Business
Table 123. Endo International Plc Latest Developments
Table 124. Eli lilly Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 125. Eli lilly Testosterone Replacement Injectables Product Portfolios and Specifications
Table 126. Eli lilly Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Eli lilly Main Business
Table 128. Eli lilly Latest Developments
Table 129. Actavis (Allergan) Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 130. Actavis (Allergan) Testosterone Replacement Injectables Product Portfolios and Specifications
Table 131. Actavis (Allergan) Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Actavis (Allergan) Main Business
Table 133. Actavis (Allergan) Latest Developments
Table 134. Bayer Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 135. Bayer Testosterone Replacement Injectables Product Portfolios and Specifications
Table 136. Bayer Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Bayer Main Business
Table 138. Bayer Latest Developments
Table 139. Novartis Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 140. Novartis Testosterone Replacement Injectables Product Portfolios and Specifications
Table 141. Novartis Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Novartis Main Business
Table 143. Novartis Latest Developments
Table 144. Teva Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 145. Teva Testosterone Replacement Injectables Product Portfolios and Specifications
Table 146. Teva Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Teva Main Business
Table 148. Teva Latest Developments
Table 149. Mylan Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 150. Mylan Testosterone Replacement Injectables Product Portfolios and Specifications
Table 151. Mylan Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Mylan Main Business
Table 153. Mylan Latest Developments
Table 154. Upsher-Smith Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 155. Upsher-Smith Testosterone Replacement Injectables Product Portfolios and Specifications
Table 156. Upsher-Smith Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157. Upsher-Smith Main Business
Table 158. Upsher-Smith Latest Developments
Table 159. Ferring Pharmaceuticals Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 160. Ferring Pharmaceuticals Testosterone Replacement Injectables Product Portfolios and Specifications
Table 161. Ferring Pharmaceuticals Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 162. Ferring Pharmaceuticals Main Business
Table 163. Ferring Pharmaceuticals Latest Developments
Table 164. Kyowa Kirin Basic Information, Testosterone Replacement Injectables Manufacturing Base, Sales Area and Its Competitors
Table 165. Kyowa Kirin Testosterone Replacement Injectables Product Portfolios and Specifications
Table 166. Kyowa Kirin Testosterone Replacement Injectables Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 167. Kyowa Kirin Main Business
Table 168. Kyowa Kirin Latest Developments



LIST OF FIGURES

Figure 1. Picture of Testosterone Replacement Injectables
Figure 2. Testosterone Replacement Injectables Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Testosterone Replacement Injectables Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Testosterone Replacement Injectables Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Testosterone Replacement Injectables Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Testosterone Replacement Injectables Sales Market Share by Country/Region (2023)
Figure 10. Testosterone Replacement Injectables Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Testosterone Undecanoate
Figure 12. Product Picture of Testosterone Cypionate
Figure 13. Product Picture of Testosterone Enanthate
Figure 14. Product Picture of Others
Figure 15. Global Testosterone Replacement Injectables Sales Market Share by Type in 2023
Figure 16. Global Testosterone Replacement Injectables Revenue Market Share by Type (2019-2024)
Figure 17. Testosterone Replacement Injectables Consumed in Hospital
Figure 18. Global Testosterone Replacement Injectables Market: Hospital (2019-2024) & (K Units)
Figure 19. Testosterone Replacement Injectables Consumed in Clinics
Figure 20. Global Testosterone Replacement Injectables Market: Clinics (2019-2024) & (K Units)
Figure 21. Testosterone Replacement Injectables Consumed in Others
Figure 22. Global Testosterone Replacement Injectables Market: Others (2019-2024) & (K Units)
Figure 23. Global Testosterone Replacement Injectables Sale Market Share by Application (2023)
Figure 24. Global Testosterone Replacement Injectables Revenue Market Share by Application in 2023
Figure 25. Testosterone Replacement Injectables Sales by Company in 2023 (K Units)
Figure 26. Global Testosterone Replacement Injectables Sales Market Share by Company in 2023
Figure 27. Testosterone Replacement Injectables Revenue by Company in 2023 ($ millions)
Figure 28. Global Testosterone Replacement Injectables Revenue Market Share by Company in 2023
Figure 29. Global Testosterone Replacement Injectables Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Testosterone Replacement Injectables Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Testosterone Replacement Injectables Sales 2019-2024 (K Units)
Figure 32. Americas Testosterone Replacement Injectables Revenue 2019-2024 ($ millions)
Figure 33. APAC Testosterone Replacement Injectables Sales 2019-2024 (K Units)
Figure 34. APAC Testosterone Replacement Injectables Revenue 2019-2024 ($ millions)
Figure 35. Europe Testosterone Replacement Injectables Sales 2019-2024 (K Units)
Figure 36. Europe Testosterone Replacement Injectables Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Testosterone Replacement Injectables Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Testosterone Replacement Injectables Revenue 2019-2024 ($ millions)
Figure 39. Americas Testosterone Replacement Injectables Sales Market Share by Country in 2023
Figure 40. Americas Testosterone Replacement Injectables Revenue Market Share by Country (2019-2024)
Figure 41. Americas Testosterone Replacement Injectables Sales Market Share by Type (2019-2024)
Figure 42. Americas Testosterone Replacement Injectables Sales Market Share by Application (2019-2024)
Figure 43. United States Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Testosterone Replacement Injectables Sales Market Share by Region in 2023
Figure 48. APAC Testosterone Replacement Injectables Revenue Market Share by Region (2019-2024)
Figure 49. APAC Testosterone Replacement Injectables Sales Market Share by Type (2019-2024)
Figure 50. APAC Testosterone Replacement Injectables Sales Market Share by Application (2019-2024)
Figure 51. China Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 55. India Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Testosterone Replacement Injectables Sales Market Share by Country in 2023
Figure 59. Europe Testosterone Replacement Injectables Revenue Market Share by Country (2019-2024)
Figure 60. Europe Testosterone Replacement Injectables Sales Market Share by Type (2019-2024)
Figure 61. Europe Testosterone Replacement Injectables Sales Market Share by Application (2019-2024)
Figure 62. Germany Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 63. France Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Testosterone Replacement Injectables Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Testosterone Replacement Injectables Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Testosterone Replacement Injectables Sales Market Share by Application (2019-2024)
Figure 70. Egypt Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Testosterone Replacement Injectables Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Testosterone Replacement Injectables in 2023
Figure 76. Manufacturing Process Analysis of Testosterone Replacement Injectables
Figure 77. Industry Chain Structure of Testosterone Replacement Injectables
Figure 78. Channels of Distribution
Figure 79. Global Testosterone Replacement Injectables Sales Market Forecast by Region (2025-2030)
Figure 80. Global Testosterone Replacement Injectables Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Testosterone Replacement Injectables Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Testosterone Replacement Injectables Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Testosterone Replacement Injectables Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Testosterone Replacement Injectables Revenue Market Share Forecast by Application (2025-2030)


More Publications